RecallRadar

FDA Drug recall D-0235-2015

TORISEL Kit (temsirolimus) injection, 25 mg/mL, 1 vial of TORISEL 25 mg/mL and 1 vial of 2.2 mL DILUENT per carton, Rx only, Distributed by…

On 2014-11-12 the FDA classified a Class III recall of TORISEL Kit (temsirolimus) injection, 25 mg/mL, 1 vial of TORISEL 25 mg/mL and 1 vial of 2.2 mL DILUENT per carton, Rx only, Distributed by… by Pfizer, citing crystallization: Impurities in a raw material used to manufacture the diluent can cause the formation of crystals in the diluent vials after cold storage. The TORISEL vials are no….

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0235-2015
ClassificationClass III
Statusterminated
Initiated2014-10-10
Published2014-11-12
Last updated2026-09-13 11:51 UTC
CompanyPfizer
DistributionUS

Product

TORISEL Kit (temsirolimus) injection, 25 mg/mL, 1 vial of TORISEL 25 mg/mL and 1 vial of 2.2 mL DILUENT per carton, Rx only, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA 19101; Diluent  MADE IN ITALY; NDC 0008-1179-01.

Reason

Crystallization: Impurities in a raw material used to manufacture the diluent can cause the formation of crystals in the diluent vials after cold storage. The TORISEL vials are not affected by this issue.

Identifiers

ndc0008-1179-01
ndc0008-1279-01
ndc0008-1125-01
code_infoKit Lot #: AIEM/13, Exp 05/16 that contain diluent lots AHZW/11 and AHZW/12

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0235-2015%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.